Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
V-type proton ATPase subunit C 2 (ATP6V1C2) is a component of the cytosolic V1 domain of vacuolar ATPase (V-ATPase), a multisubunit enzyme that acidifies intracellular organelles such as lysosomes, endosomes, and secretory vesicles in eukaryotic cells[1][3][5]. The V1 domain hydrolyzes ATP, providing the energy to drive proton transport via the membrane V0 domain; subunit C acts as a flexible stator, stabilizing the interface between the catalytic and membrane sectors and is necessary for assembly and activity regulation of the complex[2][4][8]. V-ATPase-dependent acidification is essential for key cellular processes including protein degradation, membrane trafficking, receptor-mediated endocytosis, and neurotransmitter loading into synaptic vesicles[1][3][6]. Dysfunction of V-ATPase subunits, including ATP6V1C2, has been linked to diseases such as renal tubular acidosis and may affect other pathologies related to defective organelle acidification[3][6].
Inhibition of proton transport and organelle acidification by blocking V-ATPase function
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on V-type proton ATPase subunit C 2 (ATP6V1C2).